189 related articles for article (PubMed ID: 2480138)
21. Immunoreactivity of antimitochondrial autoantibodies in Japanese patients with primary biliary cirrhosis.
Omagari K; Rowley MJ; Jois JA; Feeney SJ; Komatsu K; Maeda T; Onishi S; Yamazaki K; Suzuki K; Galperin C; Mackay IR
J Gastroenterol; 1996 Feb; 31(1):61-8. PubMed ID: 8808430
[TBL] [Abstract][Full Text] [Related]
22. Anti-mitochondrial autoantibodies of primary biliary cirrhosis as a novel probe in the study of the biosynthetic regulation of the yeast 2-oxo acid dehydrogenase complexes.
Sudoyo H; Marzuki S
Biochem Biophys Res Commun; 1989 Jan; 158(1):220-7. PubMed ID: 2643431
[TBL] [Abstract][Full Text] [Related]
23. Primary biliary cirrhosis: nature of autoantigens.
Bassendine MF; Yeaman SJ
Springer Semin Immunopathol; 1990; 12(1):73-83. PubMed ID: 1695030
[No Abstract] [Full Text] [Related]
24. Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression.
Van Norstrand MD; Malinchoc M; Lindor KD; Therneau TM; Gershwin ME; Leung PS; Dickson ER; Homburger HA
Hepatology; 1997 Jan; 25(1):6-11. PubMed ID: 8985257
[TBL] [Abstract][Full Text] [Related]
25. Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis.
Nishio A; Van de Water J; Leung PS; Joplin R; Neuberger JM; Lake J; Björkland A; Tötterman TH; Peters M; Worman HJ; Ansari AA; Coppel RL; Gershwin ME
Hepatology; 1997 May; 25(5):1085-9. PubMed ID: 9141421
[TBL] [Abstract][Full Text] [Related]
26. Autoantibody against dihydrolipoamide dehydrogenase, the E3 subunit of the 2-oxoacid dehydrogenase complexes: significance for primary biliary cirrhosis.
Maeda T; Loveland BE; Rowley MJ; Mackay IR
Hepatology; 1991 Dec; 14(6):994-9. PubMed ID: 1959888
[TBL] [Abstract][Full Text] [Related]
27. Primary biliary cirrhosis. Inhibition of pyruvate dehydrogenase complex activity by autoantibodies specific for E1 alpha, a non-lipoic acid containing mitochondrial enzyme.
Fregeau DR; Roche TE; Davis PA; Coppel R; Gershwin ME
J Immunol; 1990 Mar; 144(5):1671-6. PubMed ID: 2106552
[TBL] [Abstract][Full Text] [Related]
28. Use of designer recombinant mitochondrial antigens in the diagnosis of primary biliary cirrhosis.
Leung PS; Iwayama T; Prindiville T; Chuang DT; Ansari AA; Wynn RM; Dickson R; Coppel R; Gershwin ME
Hepatology; 1992 Mar; 15(3):367-72. PubMed ID: 1371979
[TBL] [Abstract][Full Text] [Related]
29. Differing epitope selection of experimentally-induced and natural antibodies to a disease-specific autoantigen, the E2 subunit of pyruvate dehydrogenase complex (PDC-E2).
Rowley MJ; Maeda T; Mackay IR; Loveland BE; McMullen GL; Tribbick G; Bernard CC
Int Immunol; 1992 Nov; 4(11):1245-53. PubMed ID: 1282029
[TBL] [Abstract][Full Text] [Related]
30. Natural and disease associated autoantibodies to the autoantigen, dihydrolipoamide acetyltransferase, recognise different epitopes.
Chen QY; Mackay IR; Fida S; Myers MA; Rowley MJ
J Autoimmun; 1998 Apr; 11(2):151-61. PubMed ID: 9650094
[TBL] [Abstract][Full Text] [Related]
31. Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis.
Reynoso-Paz S; Leung PS; Van De Water J; Tanaka A; Munoz S; Bass N; Lindor K; Donald PJ; Coppel RL; Ansari AA; Gershwin ME
Hepatology; 2000 Jan; 31(1):24-9. PubMed ID: 10613723
[TBL] [Abstract][Full Text] [Related]
32. The pyruvate dehydrogenase complex as a target autoantigen in primary biliary cirrhosis.
Nishio A; Coppel R; Ishibashi H; Gershwin ME
Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):535-47. PubMed ID: 10976013
[TBL] [Abstract][Full Text] [Related]
33. Detection of anti-branched chain 2-oxo acid dehydrogenase complex (BCOADC)-E2 antibody in primary biliary cirrhosis by ELISA using recombinant fusion protein.
Miyakawa H; Abe K; Kitazawa E; Kikuchi K; Fujikawa H; Matsushita M; Kawaguchi N; Kako M
Autoimmunity; 1999; 30(1):11-20. PubMed ID: 10433090
[TBL] [Abstract][Full Text] [Related]
34. Primary biliary cirrhosis. Quantitation of autoantibodies to purified mitochondrial enzymes and correlation with disease progression.
Heseltine L; Turner IB; Fussey SP; Kelly PJ; James OF; Yeaman SJ; Bassendine MF
Gastroenterology; 1990 Dec; 99(6):1786-92. PubMed ID: 2227292
[TBL] [Abstract][Full Text] [Related]
35. Primary biliary cirrhosis: current knowledge, perspectives, and future directions.
Mackay IR; Gershwin ME
Semin Liver Dis; 1989 May; 9(2):149-57. PubMed ID: 2658106
[TBL] [Abstract][Full Text] [Related]
36. Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function.
Van de Water J; Fregeau D; Davis P; Ansari A; Danner D; Leung P; Coppel R; Gershwin ME
J Immunol; 1988 Oct; 141(7):2321-4. PubMed ID: 3049806
[TBL] [Abstract][Full Text] [Related]
37. Reactivity of anti-mitochondrial autoantibodies in primary biliary cirrhosis: definition of two novel mitochondrial polypeptide autoantigens.
Frazer IH; Mackay IR; Jordan TW; Whittingham S; Marzuki S
J Immunol; 1985 Sep; 135(3):1739-45. PubMed ID: 2410503
[TBL] [Abstract][Full Text] [Related]
38. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens.
Miyakawa H; Tanaka A; Kikuchi K; Matsushita M; Kitazawa E; Kawaguchi N; Fujikawa H; Gershwin ME
Hepatology; 2001 Aug; 34(2):243-8. PubMed ID: 11481607
[TBL] [Abstract][Full Text] [Related]
39. Clarification of the identity of the major M2 autoantigen in primary biliary cirrhosis.
Fussey SP; West SM; Lindsay JG; Ragan CI; James OF; Bassendine MF; Yeaman SJ
Clin Sci (Lond); 1991 May; 80(5):451-5. PubMed ID: 1851684
[TBL] [Abstract][Full Text] [Related]
40. Fine specificity of T cells reactive to human PDC-E2 163-176 peptide, the immunodominant autoantigen in primary biliary cirrhosis: implications for molecular mimicry and cross-recognition among mitochondrial autoantigens.
Shigematsu H; Shimoda S; Nakamura M; Matsushita S; Nishimura Y; Sakamoto N; Ichiki Y; Niho Y; Gershwin ME; Ishibashi H
Hepatology; 2000 Nov; 32(5):901-9. PubMed ID: 11050037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
